Utility and Limitations of Glypican-3 Expression for the Diagnosis of Hepatocellular Carcinoma at Both Ends of the Differentiation Spectrum

Modern Pathology - United Kingdom
doi 10.1038/modpathol.2008.85
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2014English

Current Limitations and Potential Breakthroughs for the Early Diagnosis of Hepatocellular Carcinoma

Gut and Liver
HepatologyGastroenterology
2011English

Brand Equity: Both Ends of the Spectrum

Interactive Marketing
2003English

Recombinant Soluble Glypican 3 Protein Inhibits the Growth of Hepatocellular Carcinoma in Vitro

International Journal of Cancer
Cancer ResearchOncology
2010English

Limitations of Screening for Hepatocellular Carcinoma

Hepatic Oncology
HepatologyOncology
2014English

Alpha-Fetoprotein, Alpha-Fetoprotein-L3, Protein Induced by Vitamin K Absence, Glypican 3 and Its Combinations for Diagnosis of Hepatocellular Carcinoma

Surgery, Gastroenterology and Oncology
OncologySurgeryGastroenterology
2019English

Radiofrequency Ablation for Hepatocellular Carcinoma Induces Glypican-3 Peptide-Specific Cytotoxic T Lymphocytes

International Journal of Oncology
Cancer ResearchOncology
2011English

Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2015English

Inadvertent Environmentalism and the Action–value Opportunity: Reflections From Studies at Both Ends of the Generational Spectrum

Local Environment
DevelopmentManagementMonitoringPlanningPolicyLawGeography
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy